Press "Enter" to skip to content

New patent for Helsinn Hlthcare drug TRUSELTIQ

0
Copyright © DrugPatentWatch. Originally published at New patent for Helsinn Hlthcare drug TRUSELTIQ

Annual Drug Patent Expirations for TRUSELTIQ
Annual Drug Patent Expirations for TRUSELTIQ

Truseltiq is a drug marketed by Helsinn Hlthcare and is included in one NDA. There are three patents protecting this drug.

This drug has one hundred and sixteen patent family members in forty countries.

The generic ingredient in TRUSELTIQ is infigratinib phosphate. Additional details are available on the infigratinib phosphate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Helsinn Hlthcare drug TRUSELTIQ
DrugPatentWatch - Make Better Decisions